| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | Chief Commercial Officer
1 company
Heerma Peter serves as a Chief Commercial Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 27 sells. Those positions are worth an estimated $8.3M at current prices.
Historically, Heerma Peter's trades have earned a middling insider score of 53/100 across 21 rated trades. Over a 12-month horizon, 31.3% of those trades were profitable, with an average 12-month return of -26.6%.
The biggest single holding is TVTX (~$8.3M) as Chief Commercial Officer. The recent filings there lean toward selling, a net 74,545 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 7,215 | $41.93 | $302,516.29 | -4.9% | +34.3% | - | |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 7,310 | $32.12 | $234,797.20 | -5.3% | +34.3% | - | |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 4,980 | $40.00 | $199,200.00 | -4.2% | -33.5% | - | |
| Oct 31, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 5,591 | $35.00 | $195,685.00 | -4.5% | -9.0% | - | |
| Oct 28, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,662 | $30.00 | $79,860.00 | -2.1% | +0.4% | - | |
| May 5, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sale+OE | 1,771 | $21.05 | $37,279.55 | -1.4% | -25.5% | +109.2% | |
| Feb 12, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sale+OE | 5,642 | $24.33 | $137,275.55 | -2.2% | -9.7% | +31.9% | |
| Feb 3, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 5,166 | $20.12 | $103,939.92 | -4.0% | +5.9% | +62.4% | |
| Jan 22, 2025 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 1,584 | $18.94 | $30,002.23 | -1.5% | -18.4% | +52.8% | |
| Sep 9, 2024 | TVTX Travere Therapeutics, Inc. | Chief Commercial Officer | Sell | 2,191 | $11.52 | $25,240.32 | -2.0% | +46.0% | +68.3% |